======= MSTN ======= == Gene Information == * **Official Symbol**: MSTN * **Official Name**: myostatin * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2660|2660]] * **UniProt**: [[https://www.uniprot.org/uniprot/O14793|O14793]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MSTN&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MSTN|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601788|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein negatively regulates skeletal muscle cell proliferation and differentiation. Mutations in this gene are associated with increased skeletal muscle mass in humans and other mammals. [provided by RefSeq, Jul 2016]. * **UniProt Summary**: Acts specifically as a negative regulator of skeletal muscle growth. {ECO:0000250|UniProtKB:O08689}. |TGF beta| |TGFb propeptide| |negative regulation of skeletal muscle tissue growth| |negative regulation of myoblast proliferation| |negative regulation of skeletal muscle cell proliferation| |myoblast migration involved in skeletal muscle regeneration| |negative regulation of skeletal muscle satellite cell proliferation| |negative regulation of satellite cell differentiation| |regulation of skeletal muscle tissue growth| |negative regulation of skeletal muscle cell differentiation| |skeletal muscle atrophy| |striated muscle atrophy| |muscle atrophy| |response to gravity| |negative regulation of skeletal muscle tissue development| |skeletal muscle adaptation| |regulation of myoblast proliferation| |regulation of skeletal muscle satellite cell proliferation| |myoblast migration| |regulation of skeletal muscle cell proliferation| |positive regulation of macrophage chemotaxis| |regulation of skeletal muscle cell differentiation| |positive regulation of macrophage migration| |positive regulation of lamellipodium assembly| |muscle cell cellular homeostasis| |muscle cell migration| |response to muscle activity| |negative regulation of myoblast differentiation| |regulation of macrophage chemotaxis| |striated muscle adaptation| |negative regulation of muscle hypertrophy| |positive regulation of lamellipodium organization| |cellular response to dexamethasone stimulus| |regulation of lamellipodium assembly| |muscle adaptation| |negative regulation of insulin receptor signaling pathway| |skeletal muscle tissue regeneration| |negative regulation of cellular response to insulin stimulus| |regulation of macrophage migration| |response to testosterone| |response to dexamethasone| |regulation of lamellipodium organization| |transforming growth factor beta receptor binding| |regulation of granulocyte chemotaxis| |ovulation cycle process| |response to electrical stimulus| |regulation of mononuclear cell migration| |negative regulation of protein kinase B signaling| |positive regulation of pathway-restricted SMAD protein phosphorylation| |negative regulation of striated muscle tissue development| |regulation of skeletal muscle tissue development| |negative regulation of muscle organ development| |negative regulation of muscle tissue development| |regulation of myoblast differentiation| |cellular response to glucocorticoid stimulus| |SMAD protein signal transduction| |regulation of muscle hypertrophy| |cellular response to corticosteroid stimulus| |regulation of pathway-restricted SMAD protein phosphorylation| |tissue regeneration| |regulation of insulin receptor signaling pathway| |response to activity| |ovulation cycle| |regulation of cellular response to insulin stimulus| |response to estrogen| |positive regulation of leukocyte chemotaxis| |cellular response to ketone| |response to antineoplastic agent| |positive regulation of plasma membrane bounded cell projection assembly| |transforming growth factor beta receptor signaling pathway| |positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |negative regulation of developmental growth| |response to heat| |regulation of leukocyte chemotaxis| |response to ethanol| |positive regulation of leukocyte migration| |regulation of striated muscle tissue development| |regulation of muscle tissue development| |regulation of muscle organ development| |positive regulation of chemotaxis| |response to glucocorticoid| |cellular response to transforming growth factor beta stimulus| |regeneration| |response to corticosteroid| |response to transforming growth factor beta| |growth factor activity| |heparin binding| |cytokine activity| |response to temperature stimulus| |cellular response to xenobiotic stimulus| |cellular response to steroid hormone stimulus| |response to ketone| |regulation of leukocyte migration| |transmembrane receptor protein serine/threonine kinase signaling pathway| |regulation of plasma membrane bounded cell projection assembly| |regulation of cell projection assembly| |regulation of chemotaxis| |regulation of protein kinase B signaling| |response to alcohol| |regulation of muscle system process| |regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |negative regulation of growth| |negative regulation of kinase activity| |rhythmic process| |negative regulation of transferase activity| |muscle organ development| |muscle system process| |response to xenobiotic stimulus| |response to antibiotic| |response to steroid hormone| |regulation of developmental growth| |signaling receptor binding| |anatomical structure homeostasis| |positive regulation of cell projection organization| |developmental growth| |growth| |cellular response to drug| |negative regulation of phosphorylation| |muscle structure development| |wound healing| |positive regulation of cell migration| |cellular response to growth factor stimulus| |response to toxic substance| |negative regulation of intracellular signal transduction| |positive regulation of cellular component biogenesis| |cellular response to lipid| |positive regulation of cell motility| |response to growth factor| |positive regulation of cellular component movement| |cellular response to organic cyclic compound| |positive regulation of locomotion| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |response to wounding| |regulation of system process| |positive regulation of response to external stimulus| |cellular response to hormone stimulus| |regulation of growth| |negative regulation of cell population proliferation| |regulation of plasma membrane bounded cell projection organization| |regulation of cell projection organization| |negative regulation of cell differentiation| |enzyme linked receptor protein signaling pathway| |regulation of MAPK cascade| |negative regulation of catalytic activity| |multicellular organismal reproductive process| |multicellular organism reproduction| |regulation of cell migration| |response to lipid| |regulation of kinase activity| |protein homodimerization activity| |cellular homeostasis| |response to hormone| |regulation of cell motility| |response to organic cyclic compound| |negative regulation of developmental process| |regulation of cellular component biogenesis| |cell migration| |regulation of transferase activity| |regulation of locomotion| |regulation of cellular component movement| |positive regulation of protein phosphorylation| |response to drug| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |identical protein binding| |cell motility| |localization of cell| |regulation of response to external stimulus| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |negative regulation of molecular function| |positive regulation of immune system process| |response to abiotic stimulus| |negative regulation of multicellular organismal process| |positive regulation of cellular component organization| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |negative regulation of signal transduction| |locomotion| |negative regulation of cell communication| |negative regulation of signaling| |reproductive process| |reproduction| |regulation of protein phosphorylation| |response to endogenous stimulus| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |movement of cell or subcellular component| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of phosphorylation| |extracellular space| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |cell development| |positive regulation of signal transduction| |regulation of immune system process| |regulation of cell death| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |tissue development| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |system process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp287|HMS-I2 5μM R06 exp287]]|-1.92| |[[:results:exp275|Citral 75μM R06 exp275]]|-1.8| |[[:results:exp134|MS023 2μM R03 exp134]]|1.71| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|1.97| ^Gene^Correlation^ |[[:human genes:p:prim1|PRIM1]]|0.492| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18009 * **Expression level (log2 read counts)**: -0.16 {{:chemogenomics:nalm6 dist.png?nolink |}}